vs

Side-by-side financial comparison of AURORA CANNABIS INC (ACB) and IMAX CORP (IMAX). Click either name above to swap in a different company.

IMAX CORP is the larger business by last-quarter revenue ($125.2M vs $81.6M, roughly 1.5× AURORA CANNABIS INC). IMAX CORP runs the higher net margin — 0.5% vs -756.4%, a 756.9% gap on every dollar of revenue. IMAX CORP produced more free cash flow last quarter ($28.0M vs $-8.6M).

Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. ...

IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.

ACB vs IMAX — Head-to-Head

Bigger by revenue
IMAX
IMAX
1.5× larger
IMAX
$125.2M
$81.6M
ACB
Higher net margin
IMAX
IMAX
756.9% more per $
IMAX
0.5%
-756.4%
ACB
More free cash flow
IMAX
IMAX
$36.6M more FCF
IMAX
$28.0M
$-8.6M
ACB

Income Statement — Q1 FY2024 vs Q4 FY2025

Metric
ACB
ACB
IMAX
IMAX
Revenue
$81.6M
$125.2M
Net Profit
$-617.0M
$637.0K
Gross Margin
8.7%
57.6%
Operating Margin
-73.7%
19.3%
Net Margin
-756.4%
0.5%
Revenue YoY
35.1%
Net Profit YoY
-88.0%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACB
ACB
IMAX
IMAX
Q4 25
$125.2M
Q3 25
$106.7M
Q2 25
$91.7M
Q1 25
$86.7M
Q4 24
$92.7M
Q3 24
$91.5M
Q2 24
$89.0M
Q1 24
$79.1M
Net Profit
ACB
ACB
IMAX
IMAX
Q4 25
$637.0K
Q3 25
$20.7M
Q2 25
$11.3M
Q1 25
$2.3M
Q4 24
$5.3M
Q3 24
$13.9M
Q2 24
$3.6M
Q1 24
$3.3M
Gross Margin
ACB
ACB
IMAX
IMAX
Q4 25
57.6%
Q3 25
63.1%
Q2 25
58.5%
Q1 25
61.4%
Q4 24
52.2%
Q3 24
55.8%
Q2 24
49.4%
Q1 24
59.3%
Operating Margin
ACB
ACB
IMAX
IMAX
Q4 25
19.3%
Q3 25
27.2%
Q2 25
15.6%
Q1 25
19.3%
Q4 24
10.3%
Q3 24
21.2%
Q2 24
3.2%
Q1 24
15.3%
Net Margin
ACB
ACB
IMAX
IMAX
Q4 25
0.5%
Q3 25
19.4%
Q2 25
12.3%
Q1 25
2.7%
Q4 24
5.7%
Q3 24
15.2%
Q2 24
4.0%
Q1 24
4.1%
EPS (diluted)
ACB
ACB
IMAX
IMAX
Q4 25
$0.02
Q3 25
$0.37
Q2 25
$0.20
Q1 25
$0.04
Q4 24
$0.09
Q3 24
$0.26
Q2 24
$0.07
Q1 24
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACB
ACB
IMAX
IMAX
Cash + ST InvestmentsLiquidity on hand
$151.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$337.9M
Total Assets
$894.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACB
ACB
IMAX
IMAX
Q4 25
$151.2M
Q3 25
$143.1M
Q2 25
$109.3M
Q1 25
$97.1M
Q4 24
$100.6M
Q3 24
$104.5M
Q2 24
$91.6M
Q1 24
$81.0M
Stockholders' Equity
ACB
ACB
IMAX
IMAX
Q4 25
$337.9M
Q3 25
$349.5M
Q2 25
$320.4M
Q1 25
$299.5M
Q4 24
$299.5M
Q3 24
$289.4M
Q2 24
$267.2M
Q1 24
$258.8M
Total Assets
ACB
ACB
IMAX
IMAX
Q4 25
$894.0M
Q3 25
$889.6M
Q2 25
$868.6M
Q1 25
$848.3M
Q4 24
$830.4M
Q3 24
$847.6M
Q2 24
$827.4M
Q1 24
$824.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACB
ACB
IMAX
IMAX
Operating Cash FlowLast quarter
$-4.3M
$29.4M
Free Cash FlowOCF − Capex
$-8.6M
$28.0M
FCF MarginFCF / Revenue
-10.6%
22.3%
Capex IntensityCapex / Revenue
5.3%
1.1%
Cash ConversionOCF / Net Profit
46.11×
TTM Free Cash FlowTrailing 4 quarters
$118.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACB
ACB
IMAX
IMAX
Q4 25
$29.4M
Q3 25
$67.5M
Q2 25
$23.2M
Q1 25
$7.0M
Q4 24
$11.5M
Q3 24
$35.3M
Q2 24
$35.0M
Q1 24
$-11.0M
Free Cash Flow
ACB
ACB
IMAX
IMAX
Q4 25
$28.0M
Q3 25
$64.8M
Q2 25
$20.9M
Q1 25
$5.3M
Q4 24
$6.9M
Q3 24
$34.2M
Q2 24
$33.5M
Q1 24
$-12.1M
FCF Margin
ACB
ACB
IMAX
IMAX
Q4 25
22.3%
Q3 25
60.7%
Q2 25
22.8%
Q1 25
6.1%
Q4 24
7.4%
Q3 24
37.3%
Q2 24
37.6%
Q1 24
-15.3%
Capex Intensity
ACB
ACB
IMAX
IMAX
Q4 25
1.1%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
1.9%
Q4 24
5.0%
Q3 24
1.2%
Q2 24
1.8%
Q1 24
1.4%
Cash Conversion
ACB
ACB
IMAX
IMAX
Q4 25
46.11×
Q3 25
3.27×
Q2 25
2.06×
Q1 25
2.99×
Q4 24
2.16×
Q3 24
2.54×
Q2 24
9.78×
Q1 24
-3.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACB
ACB

Segment breakdown not available.

IMAX
IMAX

Technology Sales$46.6M37%
Image Enhancement And Maintenance Services$38.1M30%
Joint Revenue Sharing Arrangement$20.4M16%
Maintenance$16.3M13%
Finance Income$2.8M2%
Other Content Solutions$1.6M1%

Related Comparisons